Seeking Alpha (Free subscription) | 10/07/2008
Dividends4Life submits: Recent gyrations in the market have caused more than one investor some heartburn. Each day I hear disgruntled comments due to losses and see many people looking for an out. Ryan Detrick, senior technical strategist at Schaeffer's Investment Research said: Complete Story ยป
Market Wire - Investment Opinion (Free subscription) | 10/06/2008
LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for ConocoPhillips (NYSE: COP), Ford Motor Company (NYSE: F),...
The Street (Free subscription) | 10/01/2008
The company announced a favorable ruling in its patent case against Boston Scientific.
Brass and Ivory (Free subscription) | 10/01/2008
In less than three weeks, I will be traveling to speak at a conference specifically for Johnson & Johnson worldwide communication employees. The keynote session in which I am participating will discuss the fundamental shift of communications caused by social media (like our blogs) from the strict broadcast mode to one of conversations between people and companies. I'm told that companies like J &...
The Street (Free subscription) | 10/01/2008
Amgen's Aranesp and Johnson & Johnson's Procrit may increase the risk of death in cancer patients and lower overall survival.
Celebrity Baby Blog (Free subscription) | 10/01/2008
Timi & Leslie Bag Johnson & Johnson has long been known as a go-to brand for baby skincare, and Timi & Leslie is a hip handbag brand with some gorgeous new diaper bags and an A-list clientele. So it would...
PR News Wire (Free subscription) | 10/01/2008
ZURICH, Switzerland, October 1 /PRNewswire-FirstCall/ -- - Share Exchange Offer to the Holders of the Following Securities - Shares of Johnson & Johnson - ISIN: US4781601046 - Symbol: JNJ The K&N Value Select Corporation offers the holders of the securities named above for every 1 Johnson & Johnson share a change into 1 share of K&N Value Select Corp. - ISIN: CH0006603085 - Symbol: KN4 . The...
Denver Post (Free subscription) | 10/01/2008
Johnson & Johnson said a U.S. judge has awarded the company $1.2 billion in an 11-year patent battle with Medtronic Inc. and Boston Scientific Corp. over devices that prop open heart arteries after they're cleared of fat.
Indian Express (Free subscription) | 10/01/2008
Advinus Therapeutics, a company owned by the Tata group, has entered into a drug discovery and development collaboration with the US-based Ortho-McNeil-Janssen Pharmaceuticals Inc, a part of Johnson & Johnson, to develop two drug candidates for various disease targets.
Fiercebiotech (Free subscription) | 09/30/2008
India's Advinus Therapeutics announced a drug discovery and development collaboration with Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals. In the deal, Advinus will be responsible for drug discovery and early clinical development--until the completion of Phase IIa studies--while OMPJI will have an option to advance the drug candidates into late stage clinical trials and will be responsible...
Adrants (Free subscription) | 09/30/2008
For Johnson & Johnson's Aveeno label, Ogilvy commissioned a street artist to create a three-dimensional "fountain of youth" with chalk on pavement.
PR News Wire (Free subscription) | 09/29/2008
Reformulated Pre-Brush Rinse Helps Kids Brush Better for Cleaner, Brighter Smiles MORRIS PLAINS, N.J., Sept. 29 /PRNewswire/ -- The leader in the adult and children's mouthwash category, Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. introduces the new LISTERINE(R) AGENT COOL BLUE(R), a pre-brush mouthrinse that helps children, ages six and older, brush better for a cleaner, brighter...
Illinois Medical Malpractice Blog (Free subscription) | 09/28/2008
Federal health officials said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a study of stroke patients. Sixteen percent of patients who were treated with the drug, Eprex, had died three months after the study began, compared with 9 percent who were given a placebo, the FDA said in a statement. The study was testing whether Eprex could...
AAPL - BloggingStocks (Free subscription) | 09/27/2008
Filed under: Apple Inc (AAPL) , General Electric (GE) , General Motors (GM) , Johnson and Johnson (JNJ) , JPMorgan Chase (JPM) , Krispy Kreme Doughnuts (KKD) , Bank of America (BAC) , Boeing Co (BA) , Circuit City Stores (CC) , Wells Fargo (WFC) , Stocks to Buy , Stocks to Sell Another volatile week had passed over Wall Street, but by the end of it investors started breathing a sigh of relief in anticipation...
Fark.com (Free subscription) | 09/19/2008
2008-09-18 11:25:57 PM Bravo subby +1 2008-09-18 11:31:32 PM Indeed. +1 2008-09-18 11:36:13 PM Thirded+1 2008-09-18 11:40:41 PM Well done.+1 2008-09-18 11:47:23 PM +14 2008-09-18 11:47:31 PM awesome//I don't get it 2008-09-18 11:49:13 PM Just remember, the faster you get it off, the less it hurts. 2008-09-18 11:50:46 PM gause he's gonna need it.../good one Mr. subby 2008-09-18 11:51:57 PM +ELEVENTY!!...
